| For: | Ormandy LA, Färber A, Cantz T, Petrykowska S, Wedemeyer H, Hörning M, Lehner F, Manns MP, Korangy F, Greten TF. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(20): 3275-3282 [PMID: 16718852 DOI: 10.3748/wjg.v12.i20.3275] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i20/3275.htm |
| Number | Citing Articles |
| 1 |
Ekaterina Breous, Robert Thimme. Potential of immunotherapy for hepatocellular carcinoma. Journal of Hepatology 2011; 54(4) doi: 10.1016/j.jhep.2010.10.013
|
| 2 |
Jingnan Xu, Zhuo Song, Qiujun Guo, Jie Li. Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells. BioMed Research International 2016; 2016 doi: 10.1155/2016/1490738
|
| 3 |
Fang Zhao, Christine Falk, Wolfram Osen, Masashi Kato, Dirk Schadendorf, Viktor Umansky. Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic inRetTransgenic Mice Spontaneously Developing Melanoma. Clinical Cancer Research 2009; 15(13) doi: 10.1158/1078-0432.CCR-09-0399
|
| 4 |
. 2022; doi: 10.70675/efdce307z32b7z4fb2zb5b6zc9e216f0593a
|
| 5 |
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20) doi: 10.18632/oncotarget.15406
|
| 6 |
Kyle K Payne, Hussein F Aqbi, Savannah E Butler, Laura Graham, Rebecca C Keim, Wen Wan, Michael O Idowu, Harry D Bear, Xiang-Yang Wang, Masoud H Manjili. Gr1−/lowCD11b−/lowMHCII+ myeloid cells boost T cell anti-tumor efficacy. Journal of Leukocyte Biology 2018; 104(6) doi: 10.1002/JLB.5A0717-276RR
|
| 7 |
Dmitry I. Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo Bronte. Coordinated regulation of myeloid cells by tumours. Nature Reviews Immunology 2012; 12(4) doi: 10.1038/nri3175
|
| 8 |
Annalisa Legitimo, Rita Consolini, Alessandra Failli, Giulia Orsini, Roberto Spisni. Dendritic cell defects in the colorectal cancer. Human Vaccines & Immunotherapeutics 2014; 10(11) doi: 10.4161/hv.29857
|
| 9 |
Benjamin Ruf, Bernd Heinrich, Tim F. Greten. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cellular & Molecular Immunology 2021; 18(1) doi: 10.1038/s41423-020-00572-w
|
| 10 |
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease. International Journal of Molecular Sciences 2013; 14(11) doi: 10.3390/ijms141122022
|
| 11 |
Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(17) doi: 10.3390/cancers13174387
|
| 12 |
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155250
|
| 13 |
Charlotte Rennert, Julia Lang‐Meli, Mikhail Gromak, Maike Hofmann, Robert Thimme, Natascha Roehlen. Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment. Liver Cancer International 2023; 4(1) doi: 10.1002/lci2.70
|
| 14 |
Eunjeong Kim. Tumor Immune Microenvironment as a New Therapeutic Target for
Hepatocellular Carcinoma Development. Development & Reproduction 2023; 27(4) doi: 10.12717/DR.2023.27.4.167
|
| 15 |
Suresh Kalathil, Amit A. Lugade, Austin Miller, Renuka Iyer, Yasmin Thanavala. Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality. Cancer Research 2013; 73(8) doi: 10.1158/0008-5472.CAN-12-3381
|
| 16 |
Jana C Mossanen, Frank Tacke. Role of lymphocytes in liver cancer. OncoImmunology 2013; 2(11) doi: 10.4161/onci.26468
|
| 17 |
Silvia Martin Lluesma, Michele Graciotti, Cheryl Lai-Lai Chiang, Lana E. Kandalaft. Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?. Vaccines 2018; 6(4) doi: 10.3390/vaccines6040079
|
| 18 |
Angela D Pardee, Jian Shi, Lisa H Butterfield. Tumor-Derived α-Fetoprotein Impairs the Differentiation and T Cell Stimulatory Activity of Human Dendritic Cells. The Journal of Immunology 2014; 193(11) doi: 10.4049/jimmunol.1400725
|
| 19 |
Yu-Peng Hong, Zi-Duo Li, Pankaj Prasoon, Qi Zhang. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World Journal of Hepatology 2015; 7(7): 980-992 doi: 10.4254/wjh.v7.i7.980
|
| 20 |
. 2011; doi: 10.70675/8f9f5d3bz785dz404az8a14z18c6b1abe5f6
|
| 21 |
|
| 22 |
Yang Ma, Galina V. Shurin, Dmitriy W. Gutkin, Michael R. Shurin. Tumor associated regulatory dendritic cells. Seminars in Cancer Biology 2012; 22(4) doi: 10.1016/j.semcancer.2012.02.010
|
| 23 |
Michael R. Shurin, Viktor Umansky. Encyclopedia of Immunobiology. 2026; doi: 10.1016/B978-0-128-24465-4.00009-0
|
| 24 |
Jyh-Chiang E. Wang, James J. Kobie, Li Zhang, Matthew Cochran, Tim R. Mosmann, Christopher T. Ritchlin, Sally A. Quataert. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. Journal of Immunological Methods 2009; 341(1-2) doi: 10.1016/j.jim.2008.11.002
|
| 25 |
Tobias Flecken, Hans Christian Spangenberg, Robert Thimme. Immunobiology of hepatocellular carcinoma. Langenbeck's Archives of Surgery 2012; 397(5) doi: 10.1007/s00423-011-0783-x
|
| 26 |
Differential ratios of fish/corn oil ameliorated the colon carcinoma in rat by altering intestinal intraepithelial CD8+ T lymphocytes, dendritic cells population and modulating the intracellular cytokines. Biomedicine & Pharmacotherapy 2018; 98 doi: 10.1016/j.biopha.2017.12.041
|
| 27 |
Yeonsoo Kim, Yunseo Park, Hyunsoo Rho, Tiantian Yao, Bin Gao, Seonghwan Hwang. Inflammation in MASLD progression and cancer. JHEP Reports 2025; 7(8) doi: 10.1016/j.jhepr.2025.101414
|
| 28 |
. 2019; doi: 10.70675/ddbff38dza323z44b2za1ddzc96f4d14950e
|
| 29 |
Michael R. Shurin, Anton A. Keskinov. Encyclopedia of Immunobiology. 2016; doi: 10.1016/B978-0-12-374279-7.17014-6
|
| 30 |
Vasily Kurilin, Alina Alshevskaya, Sergey Sennikov. Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases. Biomedicines 2024; 12(3) doi: 10.3390/biomedicines12030699
|
| 31 |
Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W. Beury, Virginia K. Clements. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Seminars in Cancer Biology 2012; 22(4) doi: 10.1016/j.semcancer.2012.01.011
|
| 32 |
|
| 33 |
Stefania Mantovani, Barbara Oliviero, Andrea Lombardi, Stefania Varchetta, Dalila Mele, Angelo Sangiovanni, Giorgio Rossi, Matteo Donadon, Guido Torzilli, Cristiana Soldani, Camillo Porta, Paolo Pedrazzoli, Silvia Chiellino, Roberto Santambrogio, Enrico Opocher, Marcello Maestri, Stefano Bernuzzi, Armando Rossello, Sophie Clément, Claudio De Vito, Laura Rubbia‐Brandt, Francesco Negro, Mario U. Mondelli. Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma. Hepatology 2019; 69(3) doi: 10.1002/hep.30235
|
| 34 |
Giulia Orsini, Annalisa Legitimo, Alessandra Failli, Paola Ferrari, Andrea Nicolini, Roberto Spisni, Paolo Miccoli, Rita Consolini. Quantification of Blood Dendritic Cells in Colorectal Cancer Patients During the Course of Disease. Pathology & Oncology Research 2014; 20(2) doi: 10.1007/s12253-013-9691-4
|
| 35 |
Seo-Young Koo, Eun-Ji Park, Chang-Woo Lee. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Experimental & Molecular Medicine 2020; 52(8) doi: 10.1038/s12276-020-0480-3
|
| 36 |
Xiaopei Hao, Guangshun Sun, Yao Zhang, Xiangyi Kong, Dawei Rong, Jinhua Song, Weiwei Tang, Xuehao Wang. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.775462
|
| 37 |
Zhengkun Tu, Heli K. Hamalainen-Laanaya, Chiaki Nishitani, Yoshio Kuroki, Ian Nicholas Crispe, Mark S. Orloff. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation. International Immunology 2012; 24(2) doi: 10.1093/intimm/dxr104
|
| 38 |
Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.724883
|
| 39 |
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, Gennaro Ciliberto, Franco M Buonaguro, Luigi Buonaguro. Combinatorial immunotherapy strategies for hepatocellular carcinoma. Current Opinion in Immunology 2016; 39 doi: 10.1016/j.coi.2016.01.005
|
| 40 |
Yuri Cho, Jimin Han, Won Kim. Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma. Journal of Liver Cancer 2019; 19(1) doi: 10.17998/jlc.19.1.1
|
| 41 |
Yutong Chen, Weiran Huang, Jian Ouyang, Jingxiang Wang, Zhengwei Xie. Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032862
|
| 42 |
Rachel Grossman, Zvi Ram. Monocyte-Derived Cells of the Brain in Malignant Gliomas. World Neurosurgery 2014; 82(6) doi: 10.1016/j.wneu.2013.01.074
|
| 43 |
Charlotte Rennert, Michael Schultheiß, Robert Thimme, Natascha Röhlen, Bertram Bengsch. Hepatocellular Carcinoma – from Immunobiology to Immunotherapy. Zeitschrift für Gastroenterologie 2026; 64(01) doi: 10.1055/a-2722-5684
|
| 44 |
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Jens Werner, Svetlana Karakhanova. Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02129
|
| 45 |
Federico Costante, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows. World Journal of Gastrointestinal Oncology 2022; 14(9): 1622-1636 doi: 10.4251/wjgo.v14.i9.1622
|
| 46 |
Denise A. Caruso, Sarah Fraser, Kellie Hardy, Gerlinda Amor, Jorinde J. Helmich, David M. Ashley. Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients. Experimental Hematology 2008; 36(12) doi: 10.1016/j.exphem.2008.07.003
|
| 47 |
. 2019; doi: 10.70675/13a32e69z1eb7z4416za3b9z5e1e77176186
|
| 48 |
Alexandre Harari, Michele Graciotti, Michal Bassani-Sternberg, Lana E. Kandalaft. Antitumour dendritic cell vaccination in a priming and boosting approach. Nature Reviews Drug Discovery 2020; 19(9) doi: 10.1038/s41573-020-0074-8
|
| 49 |
Junfei Jin, Pengpeng Zhu, Yan Liao, Jun Li, Weijia Liao, Songqing He. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection. Oncotarget 2015; 6(22) doi: 10.18632/oncotarget.4265
|
| 50 |
XINLI HUANG, JIANJIE QIN, SEN LU. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation-induced tumor growth. Molecular Medicine Reports 2014; 10(4) doi: 10.3892/mmr.2014.2479
|
| 51 |
|
| 52 |
Arshi Khanam, Shyam Kottilil. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 2022; 24(1) doi: 10.3390/ijms24010437
|
| 53 |
|
| 54 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Immunotherapy of hepatocellular carcinoma. Journal of Hepatology 2006; 45(6) doi: 10.1016/j.jhep.2006.09.004
|
| 55 |
Michael R. Shurin, Gurkamal S. Chatta. Tumor-Induced Immune Suppression. 2008; doi: 10.1007/978-0-387-69118-3_6
|
| 56 |
S M Wörmann, K N Diakopoulos, M Lesina, H Algül. The immune network in pancreatic cancer development and progression. Oncogene 2014; 33(23) doi: 10.1038/onc.2013.257
|
| 57 |
Izabela Łapuć, Andrzej Eljaszewicz, Janusz Kłoczko, Marcin Moniuszko. Rola monocytów w patogenezie przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 2014; 45(4) doi: 10.1016/j.achaem.2014.06.001
|
| 58 |
Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs‐Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt‐Wolf, Maria A. Gonzalez‐Carmona. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivo. Liver International 2014; 34(3) doi: 10.1111/liv.12284
|
| 59 |
Michael R. Shurin, Anton A. Keskinov, Gurkamal S. Chatta. Tumor-Induced Immune Suppression. 2014; doi: 10.1007/978-1-4899-8056-4_5
|
| 60 |
Angela D. Pardee, Lisa H. Butterfield. Immunotherapy of hepatocellular carcinoma. OncoImmunology 2012; 1(1) doi: 10.4161/onci.1.1.18344
|
| 61 |
Han Huang, Jiansong Fang, Xiude Fan, Tatsunori Miyata, Xiaoyue Hu, Lihe Zhang, Liangren Zhang, Yimin Cui, Zhenming Liu, Xiaoqin Wu. Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01009
|
| 62 |
Patricia M. Santos, Ashley V. Menk, Jian Shi, Allan Tsung, Greg M. Delgoffe, Lisa H. Butterfield. Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells. Cancer Immunology Research 2019; 7(6) doi: 10.1158/2326-6066.CIR-18-0513
|
| 63 |
Bastian Hoechst, Lars A. Ormandy, Matthias Ballmaier, Frank Lehner, Christine Krüger, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells. Gastroenterology 2008; 135(1) doi: 10.1053/j.gastro.2008.03.020
|
| 64 |
Kohei Shigeta, Tai Hato, Yunching Chen, Dan G. Duda. Immunotherapy of Hepatocellular Carcinoma. 2017; doi: 10.1007/978-3-319-64958-0_6
|
| 65 |
. 2021; doi: 10.70675/f74abe25z2801z481cza9b8zb9232964c1fa
|
| 66 |
Jianting Long, Bo Zhou, Heping Li, Qiangsheng Dai, Bing Zhang, Sizhong Xing, Zhirong Zeng, Wei Chen, Jianyong Yang. Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide. Immunological Investigations 2013; 42(2) doi: 10.3109/08820139.2012.744418
|
| 67 |
Guangwen Shu, Tianming Yang, Chaoyuan Wang, Hanwen Su, Meixian Xiang. Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cells. Toxicology and Applied Pharmacology 2013; 269(3) doi: 10.1016/j.taap.2013.02.019
|
| 68 |
YeunHwa Gu, Yoshiaki Fujimiya, Yuka Itokawa, Masami Oshima, Jung-Sook Choi, Toshihiro Miura, Torao Ishida. Tumoricidal Effects of β-Glucans: Mechanisms Include Both Antioxidant Activity Plus Enhanced Systemic and Topical Immunity. Nutrition and Cancer 2008; 60(5) doi: 10.1080/01635580802030884
|
| 69 |
Tim F. Greten, Michael P. Manns, Firouzeh Korangy. Myeloid derived suppressor cells in human diseases. International Immunopharmacology 2011; 11(7) doi: 10.1016/j.intimp.2011.01.003
|
| 70 |
Yanyu Miao, Jianlin Ge, Longyi Zheng, Gang Liu. Bioinspired Membrane‐Based Cancer Vaccines for Immunotherapy: Progress and Perspectives. Small 2025; 21(22) doi: 10.1002/smll.202412679
|
| 71 |
Minoru Kobayashi, Taro Kubo, Kenji Komatsu, Akira Fujisaki, Fumihito Terauchi, Shinsuke Natsui, Akinori Nukui, Shinsuke Kurokawa, Tatsuo Morita. Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0556-1
|
| 72 |
Audry Fernández, Amaury Pupo, Karel Mena-Ulecia, Carlos Gonzalez. Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives. Molecular Pharmacology 2016; 90(3) doi: 10.1124/mol.116.103804
|
| 73 |
James Yu, Vadim Zaytsev, Aimen Farooq, Anum Jalil, James Wert, Zohaib Ahmed, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00022-7
|
| 74 |
Sara Monaci, Federica Coppola, Irene Filippi, Alessandro Falsini, Fabio Carraro, Antonella Naldini. Targeting hypoxia signaling pathways in angiogenesis. Frontiers in Physiology 2024; 15 doi: 10.3389/fphys.2024.1408750
|
| 75 |
Maria A. Gonzalez‐Carmona, Veronika Lukacs‐Kornek, Anne Timmerman, Sara Shabani, Miroslaw Kornek, Annabelle Vogt, Yildiz Yildiz, Elisabeth Sievers, Ingo G.H. Schmidt‐Wolf, Wolfgang H. Caselmann, Tilman Sauerbruch, Volker Schmitz. CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†. Hepatology 2008; 48(1) doi: 10.1002/hep.22296
|
| 76 |
Xiaoqin Zheng, Wenjie Jin, Shanshan Wang, Huiguo Ding. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.729705
|
| 77 |
Tim F. Greten, Firouzeh Korangy. Clinical Dilemmas in Primary Liver Cancer. 2011; doi: 10.1002/9781119962205.ch27
|
| 78 |
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Hepatocellular Carcinoma and the Multifaceted Relationship with Its Microenvironment: Attacking the Hepatocellular Carcinoma Defensive Fortress. Cancers 2024; 16(10) doi: 10.3390/cancers16101837
|
| 79 |
Tong Liu, Zhuhui Yuan, Hao Wang, Junjie Wang, Lixiang Xue. Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10) doi: 10.1016/j.clinre.2021.101835
|
| 80 |
Kouichi Momiyama, Hidenari Nagai, Yasukiyo Sumino. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy. Cancer Chemotherapy and Pharmacology 2009; 64(2) doi: 10.1007/s00280-008-0866-8
|
| 81 |
Firouzeh Korangy, Bastian Höchst, Michael P Manns, Tim F Greten. Immunotherapy of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2010; 4(3) doi: 10.1586/egh.10.18
|
| 82 |
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, Jaba Gamrekelashvili, Fei Zhao, Heiner Wedemeyer, Frank Lehner, Michael P. Manns, Tim F. Greten, Firouzeh Korangy. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor #. Hepatology 2009; 50(3) doi: 10.1002/hep.23054
|
| 83 |
Antonio Saviano, Natascha Roehlen, Alessia Virzì, Armando Andres Roca Suarez, Yujin Hoshida, Joachim Lupberger, Thomas F. Baumert. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; doi: 10.1007/978-3-030-21540-8_15
|
| 84 |
Charlotte Rennert, Michael Schultheiß, Robert Thimme, Natascha Röhlen, Bertram Bengsch. Hepatocellular Carcinoma – from Immunobiology to Immunotherapy. TumorDiagnostik & Therapie 2026; 47(05) doi: 10.1055/a-2851-6473
|
| 85 |
Sonja Obermann, Susanne Petrykowska, Michael P. Manns, Firouzeh Korangy, Tim F. Greten. Peptide‐β2‐microglobulin‐major histocompatibility complex expressing cells are potent antigen‐presenting cells that can generate specific T cells. Immunology 2007; 122(1) doi: 10.1111/j.1365-2567.2007.02616.x
|